АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ И СКОРОСТЬ РАСПРОСТРАНЕНИЯ ПУЛЬСОВОЙ ВОЛНЫ, ВОЗМОЖНОСТИ МЕДИКАМЕНТОЗНОЙ КОРРЕКЦИИ
Аннотация
В обзоре представлена неинвазивная методика определения жесткости артерий с помощью измерения скорости распространения пульсовой волны (СРПВ). Описаны клинические исследования, демонстрирующие прогностическую значимость увеличения СРПВ у больных артериальной гипертензией (АГ). Показано, что оценка СРПВ может служить не только диагностическим критерием, но и ориентиром динамики состояния органа-мишени при лечении больных АГ. Проведен анализ эффективности влияния различных групп антигипертензивных препаратов на жесткость артерий.Литература
Беленков Ю.Н. Агеев Ф.Т., Орлова Я.А. Клинические и сосудистые эффекты комбинации ингибитора ангиотензинпревращающего фермента эналаприла и тиазидоподобного диуретика индапамида у амбулаторных больных с артериальной гипертонией: результаты многоцентрового исследования ПОЭМА // Тер. архив. – 2007. – № 8. – С. 33–38.
Кочкина М.С., Затейщиков Д.А., Сидоренко Б.А. Измерение жёсткости артерий и её клиническое значение // Кардиология. – 2005. – № 1. – С. 63-71.
Нечесова Т.А., Ливенцева М.М., Коробко И.Ю., Калинина Т.В. Влияние комбинированной антигипертензивной терапии препаратом «Экватор» на состояние органов-мишеней у больных артериальной гипертензией // Медицинские новости. – 2008. – №11. – С. 1-4.
Agabiti-Rosei E., Porteri E., Rizzoni D. Arterial stiffness, hypertension, and rational use of nebivolol // Vasc Health Risk Manag. – 2009. – V. 5. – P. 353-360.
Anan F., Takahashi N., Ooie T., et al. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension // Eur J Clin Pharmacol. – 2005. – V. 61. – P. 353-359.
Asmar R., Kerihuel J. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension // Am J Cardiol. – 1991. – V. 68. – P. 61-64.
Asmar R., Benetos A. Comparison of effects of felodipine versus hydrochlorthyaside on arterial diameter and PWV in essential hypertension // Am J Cardiol. – 1993. – V. 72. – P. 794-798.
Asmar R., London G., O’Rourke M., Safar M. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol // Hypertension. – 2001. – V. 38. – P. 922-926.
Asmar R., Topouchian J., Pannier B. et al. Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study // J Hypertens. – 2001. – V. 19. – P. 813-818.
Barenbrock M. Effect of lisinopril and metoprolol on arterial distensibility // Hypertension. – 1994. – V. 24. – P. 161-163.
Blacher J., Asmar R., Djane S. et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients // Hypertension. – 1999. – V. 33. – P. 1111-1117.
Boutouyrie P., Tropeano A.I., Asmar R. et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. A longitudinal study // Hypertension. – 2002. – V. 39. – P. 10.
Castelpoggi C., Pereira V., Fiszman R., et al. A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension // Hypertens Res. – 2009. – May 15. – [Epub ahead of print].
Du J., Ning G., Li Y., Zheng X. Arterial stiffness estimation in hypertension // Conf Proc IEEE Eng Med Biol Soc. – 2005. – V.5. – P. 5507-5510.
Fukuda M., Masuda T., Ogura M. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients // Hypertens Res. – 2009. – V. 32. – P. 392-398.
Henskens L., Kroon A., van Oostenbrugge R. et al. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients // Hypertension. – 2008. – V. 52. – P. 1120-1126.
Kosch M., Levers A., Lang D,. et al. A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension // Nephrol Dial Transplant. – 2008. – V. 23. – P. 2280-2285.
Laurent S., Boutouyrie P., Asmar R. et al. Aortic stiffnes is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients // Hypertension. – 2001. V. 37. – P. 1236–1241.
London G., Schmieder R., Calvo C., Asmar R. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study // Am J Hypertens. – 2006. – V. 19. – P. 113-121.
Mackenzie I., McEniery C., Dhakam Z. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension // Hypertension. – 2009. – Jun 1. – [Epub ahead of print].
Mahmud A., Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection // Am J Hypertens. – 2008. – V. 21. – P. 663-667.
Mulvny M.J. Changes in resistance vessels in hypertension // High Blood Press. – 1993. – Suppl. 2. – P. 40-44.
Munakata M., Miura Y., Yoshinaga K. Higher brachial-ankle pulse wave velocity as an independent risk factor for future microalbuminuria in patients with essential hypertension: the J-TOPP study // J Hypertens. – 2009. – Apr 30. – [Epub ahead of print].
Munakata M., Nagasaki A., Nunokawa T. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients // Am J Hypertens. – 2004. – V. 17. – P. 1050-1055.
Nichols W.W. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms // Am J Hypertension. – 2005. – Vol. 18. – P. 3S–10S.
Ono Y., Nakaya Y., Bando S. Telmisartan decreases plasma levels of asymmetrical dimethyl-L-arginine and improves lipid and glucose metabolism and vascular function // Int Heart J. – 2009. – V. 50. – P. 73-83.
Safar M., Laurent S., Safavian A. Sodium and large arteries in hypertension: effect of indapamide // Am J Med. – 1998. – V. 84. – P. 15-19.
Triantafyllidi H., Arvaniti C., Lekakis J. et al. Cognitive impairment is related to increased arterial stiffness and microvascular damage in patients with never-treated essential hypertension // Am J Hypertens. – 2009. – V. 22. – P. 525-530
Vyssoulis G., Karpanou E., Kyvelou S. Beneficial effect of angiotensin II type 1 receptor blocker antihypertensive treatment on arterial stiffness: the role of smoking // J Clin Hypertens (Greenwich). – 2008. – V. 10. – P. 201-207.
Wang C., Hung W., Yu T., et al. Brachial-ankle pulse wave velocity as an early indicator of left ventricular diastolic function among hypertensive subjects // Clin Exp Hypertens. – 2009. – V.31. – P. 31-43.
Wang X., Keith J.C. Struthers A.D. et al. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk // Cardiovasc Ther. – 2008. –V. 26(3). – P. 214-223.
Zhu H., Yan W., Ge D. et al Cardiovascular characteristics in American youth with prehypertension // Am J Hypertens. – 2007. – V. 20. – P. 1051-1057.
